Impact of sleep apnea and treatments on cardiovascular disease

Andre Faria1, Arthur Macedo1, Carolina Castro1

  • 1Universidade Federal de Minas Gerais, Faculdade de Medicina - Belo Horizonte - MG - Brazil.

Insights

Obstructive sleep apnea (OSA) is a significant risk factor for cardiovascular diseases (CVDs), including hypertension, atrial fibrillation, stroke, and heart failure. Treating OSA may reduce the incidence of these serious cardiovascular complications.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Public Health

Background:

  • Cardiovascular diseases (CVDs) represent a major global health burden, causing millions of deaths annually.
  • Understanding risk factors for CVDs is crucial for effective prevention and treatment strategies.
  • Sleep-disordered breathing, particularly obstructive sleep apnea (OSA), is increasingly recognized as a potential contributor to CVDs.

Purpose of the Study:

  • To review epidemiological data linking obstructive sleep apnea (OSA) with major cardiovascular outcomes.
  • To explore the proposed pathophysiological mechanisms connecting OSA and cardiovascular diseases.
  • To discuss the impact of OSA treatments on cardiovascular complication prevalence.

Main Methods:

  • Systematic review of epidemiological studies.
  • Analysis of proposed biological pathways and mechanisms.
  • Evaluation of evidence on therapeutic interventions for OSA and their cardiovascular effects.

Main Results:

  • Significant associations found between OSA and increased risk of hypertension, atrial fibrillation, stroke, atherosclerosis, and heart failure.
  • Multiple biological pathways identified, including inflammation, oxidative stress, and sympathetic nervous system activation, link OSA to cardiovascular disease.
  • Evidence suggests that treating OSA can mitigate the risk and prevalence of cardiovascular complications.

Conclusions:

  • Obstructive sleep apnea is a significant and modifiable risk factor for a wide range of cardiovascular diseases.
  • Targeting OSA through appropriate treatments offers a promising strategy to reduce the global burden of cardiovascular mortality and morbidity.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
217
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
209
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
26